Search for Clinical Trial Results
Large Granular Lymphocyte Leukemia - 27 Studies Found
Status | Study |
Completed |
Study Name: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Condition:
Interventions: |
Active, not recruiting |
Study Name: Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies Condition:
Interventions: |
Withdrawn |
Study Name: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies Condition:
|
Active, not recruiting |
Study Name: Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant Condition:
|
Active, not recruiting |
Study Name: Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma Condition:
|
RECRUITING |
Study Name: Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia Condition: T-Cell Large Granular Lymphocyte Leukemia Date: 2024-05-19 Interventions: Given PO |
RECRUITING |
Study Name: Siltuximab in Large Granular Lymphocytic Leukemia (LGLL) Condition: Large Granular Lymphocyte Leukemia Date: 2024-05-19 Interventions: Siltuximab will be given on day 1 of each cycle.The dose will be 11 mg/kg given over 1 hour by intravenous infusion.Each cycle is thr |